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doi:10.1016/j.kjms.2010.12.004Abstract Our objective was to assess the value of tumor necrosis and other factors for pre-
dicting the outcome of renal cell carcinoma (RCC). Our study comprised 328 RCC patients who
were surgically treated at this hospital between 2001 and 2006. The five-year survival data was
analyzed using a Kaplan-Meier statistical analysis. The prognostic factors were evaluated with
a univariate analysis using a log-rank test and multivariate analysis using the Cox proportional
hazards regression method. The mean follow-up period for these patients was 46.5 months
(median 45.2 months). The univariate analysis revealed that age, tumor stage, TNM stage,
grade, tumor necrosis, and histological type were statistically significant prognostic factors.
The multivariate analysis showed that the TNM stage and tumor necrosis were the most impor-
tant predictive factors in the patients’ overall survival. In the TNM stage with and without
tumor necrosis, the five-year overall survival rates in stages I þ II were 80.5% and 89.2%,
respectively (pZ 0.115), where as the five-year survival rates in stages IIIþ IV were 32.7%
and 84.0%, respectively (p< 0.001). Collectively, our present data revealed that tumor
necrosis was an important predictive factor for survival in advanced stage RCC. In conclusion,
both the TNM stage and tumor necrosis provided the most important prognostic factors of
survival in RCC. Tumor necrosis proved to be a poor prognostic factor in advanced RCCs.
摘要 我們評估腫瘤壞死與其他相關因素是否可做為腎臟癌患者預後的預測因子。從2001年到
2006年共有328位腎臟癌病患在本院接受手術。5年存活率是以Kaplan-Meier方法分析。預測因子rology, Department of Surgery, Chang Gung Memorial Hospital, 5 Fu-Shing Street, Kweishan, Taoyuan
rg.tw (C.-K. Chuang).
vier Taiwan LLC. All rights reserved.
60 Y.-H. Chang et al.則是利用單變項 (Log Rank test)與多變項 (Cox proportional hazards regression method)方法加
以分析。病患平均追蹤時間為46.5個月。單變項分析顯示年齡、腫瘤分期、TNM分期、分化程
度、腫瘤壞死、組織學形態上都有意義。多變項分析則顯示TNM分期和腫瘤壞死在病患存活上最
有意義。當我們把TNM分期和腫瘤壞死合併一起分析，在5年存活率上，stage IþII合併腫瘤有無
壞死分別為80.5%與89.2% (p Z 0.115)，stage IIIþIV合併腫瘤有無壞死分別為32.7%與84.0%
(p < 0.001)。研究顯示，腫瘤壞死在腎臟癌併有局部侵犯或遠端轉移特別有意義。總結來說，
TNM分期和腫瘤壞死在腎臟癌病患存活上是最重要預測因子。特別地，在較侵犯性腎臟癌的病
患，腫瘤壞死的現象代表較不好的預後。
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.Table 1 Patient demographics and tumor characteristics
(n Z 328)
Variables n (%)
Gender
Male 216 (65.9)
Female 112 (34.1)
Age
<65 yr 207 (63.1)
>65 yr 121 (36.8)
Tumor location
Right 174 (53.0)
Left 150 (45.7)
Rightþ left 4 (1.3)
Type of operation
Radical nephrectomy 306 (93.3)
Partial nephrectomy 22 (6.7)
Tumor stage
T1 180 (54.9)
T2 60 (18.3)
T3 83 (25.3)
T4 5 (1.5)
TNM stage
I 169 (51.5)
II 57 (17.4)
III 63 (19.2)
IV 39 (11.9)
Fuhrman grade
1 34 (10.4)
2 182 (55.5)
3 72 (22.0)
4 18 (5.5)
No grading 22 (6.6)
Tumor necrosis
Yes 139 (42.4)
No 188 (57.3)
No data 1 (0.3)
Histological type
Clear cell 232 (70.7)
Papillary 37 (11.7)
Chromophobe 37 (11.3)
Sarcomatoid 3 (0.9)
Unclassified 19 (5.8)Introduction
Renal cell carcinoma (RCC) is a common malignant tumor of
the genitourinary tract, accounting for 2%e3% of all adult
malignant tumors. Advances in imaging technology have
dramatically increased the incidence of all stages of RCC [1].
Goetzl et al. [2] reported that 51%e56% of renal cortical
tumors are diagnosed incidentally. In 1958, Flocks and
Kadesky [3] first described a tumor-staging system for RCC.
Since then, several other tumor-staging systems have been
proposed. In 1978, the TNM system, which was first used for
staging RCC,was adopted by theUnion Internationale Contre
le Cancer (UICC) [4]. Several revisions of the TNM system
have been made by the UICC and the American Joint
Committee on Cancer (AJCC). The major change in the TNM
systemoccurred in the 1997 editions of the UICC and AJCC, in
which the T1 stage was defined as a tumor size of less than
7 cmand theT2 stage as a tumor size of greater than 7 cmand
limited to the kidney. The current TNM system was modified
in 2002. In localized RCC without lymph node involvement or
distant metastasis, the staging system was subclassified,
dividing tumor stage T1 into T1a for tumors 4 cm or smaller
and T1b for tumors larger than 4 cm.
Identification of the prognostic factors for RCC is critical
for analyzing patient survival as well as for evaluating
treatment options. Several studies have revealed that the
TNM stage is the most important prognostic factor. Other
prognostic factors, such as tumor stage, nuclear grade, and
histological type, have also been found to influence the
survival rate of RCC. The role of tumor necrosis in prognosis is
still undetermined. Unfortunately, most available data thus
far have been from studies conducted in the United States,
Europe, or Japan. A thorough review of the medical litera-
ture reveals almost no data for the Taiwanese population.
Consequently, we evaluated the relationship between tumor
necrosis and RCC tissue to determine whether the presence
of tumor necrosis plays a role in predicting patient survival.
Methods
Between 2001 and 2006, we analyzed 328 RCC patients who
received surgical treatment at Chang Gung Memorial
Hospital. All information was obtained by retrospective
review of medical records. Table 1 shows the patient
demographics and tumor characteristics. Surgical treat-
ments of RCC, including a radical nephrectomy and
a partial nephrectomy, were selected according to the
judgment of the managing surgeon in conjunction with
patient preferences. Tumor staging was performed
Figure 2. Five-year overall survival curves of renal cell
carcinoma patients based on tumor necrosis.
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grade of the tumors was determined according to the
Fuhrman grading system [5]. Tumor necrosis was identified
by histological confirmation. Overall survival was deter-
mined by Kaplan-Meier statistical analysis. Prognostic
factors for survival were evaluated by univariate analysis
using the log-rank test. Significant prognostic factors were
then evaluated by multivariate analysis using the Cox
proportional hazards regression method.
Results
We analyzed the data for 328 RCC patients. The mean
follow-up period was 46.5 months (median 45.2 months)
(range 1.0e97.2 months). As shown in Table 1, the male-to-
female ratio was 1.93:1. The mean age was 59.22 years
(range 23e89 years). Of the group, 73.2% were in stages T1
and T2. Most patients (93.3%) received a radical nephrec-
tomy. Histologically, the tumor types were clear cell in
70.7%, papillary in 11.3%, chromophobe in 11.3%, sarco-
matoid in 0.9%, and unclassified in 5.8%. In 34 patients, the
Fuhrman Grade was 1 (10.4%), with a Grade 2 in 182
(55.5%), a Grade of 3 in 72 (22.0%), a Grade of 4 in 18
(5.5%), and there were 22 patients (6.6%) without grading
information. A histological identification of tumor necrosis
was available for 42.4% of the tumor tissues.
The five-year overall survival rate was 79.5% for the
women and 73.7% for the men. The survival rate was 82.3%
in T1, 84.5% in T2, 57.5% in T3, and 0.0% in T4. In TNM stage
I, the survival rate was 85.8%, and it was 85.5% in stage II,
59.1% in stage III, and 35.7% in stage IV (Fig. 1). In patients
with and without tumor necrosis, the survival rates were
60.2% and 88.8%, respectively (Fig. 2).
The univariate analysis of the influence of prognostic
factors, such as gender, age, tumor stage, TNM stage,
tumor grade, tumor necrosis, and tumor cell type on
survival revealed that age, tumor stage, TNM stage, tumor
grade, tumor necrosis, and tumor cell type were statisti-
cally significant prognostic factors (Table 2). Multivariate
analysis revealed that only the TNM stage and tumor
necrosis were the important predictive factors to patient
survival (Table 3).Figure 1. Five-year overall survival curves of renal cell
carcinoma patients based on TNM stage.Regarding tumor necrosis in the survival analysis,
a combination of the TNM stage with and without tumor
necrosis showed that the five-year overall survival rates in
Stage I were 79.0% and 89.6%, respectively (pZ 0.139); in
Stage II, 83.9% and 87.8%, (pZ 0.547); in Stage III, 38.0% and
100% (p< 0.001); and in Stage IV, 24.0% and 57.1% (pZ
0.018). When we compared the localized and the locally
advanced stage, tumor necrosis was indeed a poor prognosis
factor for the locally advanced stage group, as revealed by
the high statistical difference (p< 0.001) between TNM
stages IIIþ IV with tumor necrosis and TNM stages IIIþ IV
without tumor necrosis (Fig. 3). This was not the case
between TNM stages Iþ II with tumor necrosis and TNM
stages Iþ II without tumor necrosis (pZ 0.115) (Fig. 4).
Discussion
TNM tumor staging, used to examine primary tumor extent
(T), lymph node involvement (N), and distantmetastasis (M),
has become the most popular system for evaluating biolog-
ical tumor activity and providing insight into a patient’s
survival and prognosis. The uniform staging system was used
in this study to compare different results using the same
criteria to optimize treatment technique and protocol.
In our series, most of the RCC patients underwent
a radical nephrectomy (306 patients) rather than a partial
nephrectomy (22 patients), a trend that is different from
other studies [6]. This is likely because of the patient’s
attitude and the surgeon’s preferences. However, as more
conservative management has become widely acceptable
in the urology community, most patients with smaller
tumors and other appropriate conditions are treated with
a partial nephrectomy at our institution.
The influence of tumor size on survival rate has been
discussed extensively. Notably, in 2002 the TNM staging
system was revised. Hafez et al. [7] reported a higher
survival rate in T1a patients than in T1b patients. However,
the five-year overall survival rates for T1a and T1b in our
series were 83.5% and 89.3% (pZ 0.193), respectively.
Similar to the report of Srivastava et al. [8], we did not find
that the subclassification of T1a and T1b produced any
significant difference in survival. Our data also showed
Table 2 Univariate analysis of prognostic variables for
five-year overall survival
Prognostic factor Five-year
overall
survival (%)
p
Gender
Male 73.7 0.437
Female 79.5
Age
65 yr 79.0 0.022
>65 yr 69.9
Tumor stage
T1 82.3 <0.001
T2 84.5
T3 57.5
T4 0.0
TNM stage
I 85.8 <0.001
II 85.5
III 59.1
IV 35.7
Tumor grade
1 85.0 <0.001
2 81.8
3 66.2
4 44.4
Tumor necrosis
Yes 60.2 <0.001
No 88.8
Histological type
Clear cell 74.4 0.002
Papillary 64.0
Chromophobe 97.3
Sarcomatoid 33.3
TNM stage and tumor necrosis
Iþ II and necrosis (þ) 80.5 0.115
Iþ II and necrosis () 89.2
IIIþ IV and necrosis (þ) 32.7 <0.001
IIIþ IV and necrosis () 84.0
Figure 3. Five-year overall survival curves of renal cell
carcinoma patients based on TNM stages IIIþ IV and tumor
necrosis.
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85.5%), suggesting that tumors with locally advanced or
distant metastasis are more important than the size of the
tumor in influencing a patient’s survival.Table 3 Multivariate analysis of prognosis predictors for renal
Prognosis predictors HR
Age 1.353
Tumor stage 0.540
TNM stage (3þ 4/1þ 2) 5.095
Tumor grade (3þ 4/1þ 2) 1.248
Tumor necrosis 2.629
Histological type 1.493
CIZ confidence interval; HRZ hazards regression.Multivariate analysis showed that the TNM stage and
tumor necrosis were the most significant predictors of
patient survival. Bretheau et al. [9] showed that the tumor
grade is compatiblewith thedisease stage, postnephrectomy
distant metastasis, and patient survival. Conversely, our
study did not find such a correlation between the survival
rate and tumor grade (pZ 0.433). It would be of interest to
study the molecular mechanism behind the difference in
factors influencingRCC survivals. Pantuck et al. [10] revealed
that in RCC with lymph node invasion, the survival rate was
less than25%.Our data also revealed that tumornecrosis is an
independent factor for survival (p< 0.001). Sengupta et al.
[11] have reported that RCC with tumor necrosis has a trend
of high grade, advanced stage, lymph node invasion, and
distantmetastasis.Our present studypoints out that patients
with tumor necrosis have two to three times higher death
rate as comparedwith patientswithout necrosis. Klatte et al.
[12] and other reports [13] revealed that an increased area of
tumor necrosis means a higher T stage, metastasis, vascular
invasion, and a sarcomatoid component. Brinker et al. [14]
suggested that tumor necrosis may be the result of a tumor
proliferating rapidly and overgrowing its blood supply. Tumor
necrosis may also be because of an antitumor effect, as an
increase in lymphocyte infiltration occurs in the tumor
necrosis area [11]. Sabo et al. [15] reported that tumor
necrosis within the tumor compressed the tumor vessels,
thereby facilitating tumor cell dissemination. At presenta-
tion, patients with higher tumor stages and TNM stages alsocell carcinoma
p 95% CI
0.224 0.831 2.201
0.144 0.236 1.235
< 0.001 2.168 11.973
0.433 0.717 2.171
0.001 1.470 4.702
0.220 0.787 2.833
Figure 4. Five-year overall survival curves of renal cell
carcinoma patients based on TNM stages Iþ II and tumor
necrosis.
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For example, in Stage IV, 64.1% of the patients had tumor
necrosis, whereas in Stage I, it was only 26.2%. These results
are comparable with those observed by Sabo et al. [15]. On
the other hand, the study of Minervini et al. [16] revealed
that tumor necrosis is not a prognostic factor for RCC
survival. Sorbellini et al. [17] also reported that tumor
necrosis was a better prognostic factor in their nomogram for
predicting tumor recurrence.Whether there is a relationship
between tumor necrosis and tumor behavior was not deter-
mined. Further studies are needed to establish such
a relationship.
In conclusion, to the best of our knowledge, this is the
first study to report RCC survival data for the population of
Taiwan. TNM stage and tumor necrosis were the important
predictive factors to patient survival. Furthermore, in the
advanced stage, patients without tumor necrosis may have
a favorable survival rate. This phenomenon is more signif-
icant in advanced tumors. Our results may also serve as
baseline information for comparing treatment outcomes of
RCCs among different nations and/or ethnic groups.Acknowledgments
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